» Articles » PMID: 7835944

Stimulators of Tumour Necrosis Factor Production Released by Damaged Erythrocytes

Overview
Journal Immunology
Date 1994 Oct 1
PMID 7835944
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We sought to characterize factors released by sonicated human erythrocytes that stimulate peripheral blood mononuclear cells (PBMC) to release tumour necrosis factor-alpha (TNF). This response is not inhibited by polymyxin B, indicating that contaminating lipopolysaccharide (LPS) is not responsible. When erythrocyte lysates are fractionated by reverse-phase chromatography using a gradient of n-propanol on Sep-Pak C18 cartridges, the TNF-inducing activity elutes as a single peak. The erythrocyte-derived TNF-inducing activity is unaffected by digestion with proteases but is destroyed by mild base hydrolysis or digestion by lipases, indicating that compounds containing ester-linked acyl chains may be essential. These properties are similar to those of TNF stimulators that we have previously identified in erythrocytes infected with malaria parasites, except that the TNF-inducing activity per cell is about 200 times higher in parasitized erythrocytes than in uninfected erythrocytes. Lipase-digested erythrocyte lysates inhibit the TNF-inducing factors of both normal and malaria-infected erythrocytes, suggesting that lipase digestion creates partial structures which compete with active components for macrophage receptors. Such receptors may recognize a common structure that contains an inositol monophosphate (IMP)-like component, as IMP also inhibits the TNF response to erythrocyte-derived factors and to parasite lysates whereas it does not affect the response to LPS. We conclude that lysed erythrocytes release specific cytokine-inducing factors that may contribute to the fever response to non-infectious tissue injury.

Citing Articles

Influence of different ex vivo cell culture methods on the proliferation and anti-tumor activity of cytokine-induced killer cells from gastric cancer patients.

Shi B, Sun A, Zhang X Onco Targets Ther. 2018; 11:2657-2672.

PMID: 29780258 PMC: 5951225. DOI: 10.2147/OTT.S162281.


Cytokines and Chemokines in Cerebral Malaria Pathogenesis.

Dunst J, Kamena F, Matuschewski K Front Cell Infect Microbiol. 2017; 7:324.

PMID: 28775960 PMC: 5517394. DOI: 10.3389/fcimb.2017.00324.


Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans.

Lou J, Lucas R, Grau G Clin Microbiol Rev. 2001; 14(4):810-20, table of contents.

PMID: 11585786 PMC: 89004. DOI: 10.1128/CMR.14.4.810-820.2001.


Immunization of mice with phosphatidylcholine drastically reduces the parasitaemia of subsequent Plasmodium chabaudi chabaudi blood-stage infections.

Bordmann G, Rudin W, Favre N Immunology. 1998; 94(1):35-40.

PMID: 9708184 PMC: 1364328. DOI: 10.1046/j.1365-2567.1998.00479.x.


Sera from patients with falciparum malaria induce substance P gene expression in cultured human brain microvascular endothelial cells.

Chiwakata C, Hort G, Hemmer C, Dietrich M Infect Immun. 1996; 64(12):5106-10.

PMID: 8945553 PMC: 174495. DOI: 10.1128/iai.64.12.5106-5110.1996.


References
1.
TRAGER W, Jensen J . Human malaria parasites in continuous culture. Science. 1976; 193(4254):673-5. DOI: 10.1126/science.781840. View

2.
Morrison D, Jacobs D . Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry. 1976; 13(10):813-8. DOI: 10.1016/0019-2791(76)90181-6. View

3.
Bate C, Taverne J, Playfair J . Malarial parasites induce TNF production by macrophages. Immunology. 1988; 64(2):227-31. PMC: 1384947. View

4.
Roberts W, Santikarn S, Reinhold V, Rosenberry T . Structural characterization of the glycoinositol phospholipid membrane anchor of human erythrocyte acetylcholinesterase by fast atom bombardment mass spectrometry. J Biol Chem. 1988; 263(35):18776-84. View

5.
Kwiatkowski D, Cannon J, Manogue K, Cerami A, Dinarello C, Greenwood B . Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin Exp Immunol. 1989; 77(3):361-6. PMC: 1542045. View